Journal article
The impact of purinergic signaling on renal ischemia-reperfusion injury
B Lu, SV Rajakumar, SC Robson, EKF Lee, S Crikis, AJF D'Apice, PJ Cowan, KM Dwyer
Transplantation | Published : 2008
Abstract
BACKGROUND.: Adenosine provides renovascular protection in mouse models of ischemia-reperfusion injury (I/RI) through purinergic members of the G protein-coupled receptor family, such as the adenosine 2A receptor (A2AR). Ectonucleotidases CD39 and CD73 are integral vascular and immune nucleotidases that regulate extracellular adenosine signaling. Current investigation of CD39 and CD73 in renal I/RI has primarily focused on their respective roles in ischemic preconditioning. METHODS.: In this study, we established a unilateral renal I/RI model and investigated the role of adenosine generation versus nucleotide removal in mediating protection in renal I/RI using mice deficient in CD39, CD73 or..
View full abstractGrants
Awarded by National Institute of Allergy and Infectious Diseases
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (grant no. 447706), Genzyme Renal Innovations Program, and National Institutes of Health (NIH) of USA.